HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang Xu Selected Research

isovitexin

1/2020Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression.
1/2020Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells.
6/2019Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
1/2019Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang Xu Research Topics

Disease

131Neoplasms (Cancer)
08/2022 - 07/2005
27Inflammation (Inflammations)
04/2022 - 07/2013
19Hepatocellular Carcinoma (Hepatoma)
04/2022 - 01/2017
13Lung Neoplasms (Lung Cancer)
10/2022 - 06/2016
12Carcinogenesis
01/2021 - 06/2010
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2018
10Asthma (Bronchial Asthma)
01/2022 - 05/2009
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2013
9Spinal Cord Injuries (Spinal Cord Injury)
09/2021 - 04/2018
9Congenital Diaphragmatic Hernias
03/2016 - 02/2007
8Rheumatoid Arthritis
04/2022 - 11/2019
8Infections
01/2021 - 10/2013
7Breast Neoplasms (Breast Cancer)
10/2022 - 04/2016
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2014
6COVID-19
01/2022 - 01/2021
6Hypoxia (Hypoxemia)
01/2022 - 01/2010
6Genomic Instability
01/2021 - 03/2006
5Pain (Aches)
07/2022 - 06/2019
5Neoplasm Metastasis (Metastasis)
01/2020 - 06/2010
5Squamous Cell Carcinoma of Head and Neck
01/2018 - 06/2010
4Airway Remodeling
07/2022 - 01/2019
4Circulating Neoplastic Cells
01/2022 - 01/2017
4Osteoporosis
01/2022 - 01/2019
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 11/2019
4Diabetes Mellitus
01/2022 - 09/2018
4Weight Gain
01/2021 - 01/2018
4Prostatic Neoplasms (Prostate Cancer)
12/2020 - 11/2007
4Hyperplasia
03/2020 - 08/2006
4Acute Kidney Injury (Acute Renal Failure)
01/2020 - 12/2015
4Adenocarcinoma
01/2017 - 06/2010
4Pulmonary Hypertension
09/2015 - 02/2007
3Necrosis
08/2022 - 10/2013
3Hypersensitivity (Allergy)
07/2022 - 12/2017
3Pelvic Pain
06/2022 - 01/2021
3Cognitive Dysfunction
04/2022 - 07/2014
3Hypertension (High Blood Pressure)
04/2022 - 01/2017
3Rupture
01/2022 - 01/2017
3Hemorrhage
12/2021 - 06/2014
3Rheumatic Diseases (Rheumatism)
09/2021 - 01/2018
3Brain Ischemia (Cerebral Ischemia)
12/2020 - 07/2014
3Reperfusion Injury
12/2020 - 10/2014
3Sepsis (Septicemia)
11/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2005
19DNA (Deoxyribonucleic Acid)IBA
11/2021 - 06/2010
16Biological ProductsIBA
10/2022 - 08/2009
12Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2013
12Pharmaceutical PreparationsIBA
08/2020 - 07/2013
11CytokinesIBA
10/2022 - 07/2013
11RNA (Ribonucleic Acid)IBA
05/2022 - 01/2013
10Messenger RNA (mRNA)IBA
01/2022 - 06/2009
9GoldIBA
04/2022 - 01/2017
9Peptides (Polypeptides)IBA
01/2022 - 03/2007
9MicroRNAs (MicroRNA)IBA
01/2022 - 09/2012
8Therapeutic UsesIBA
01/2022 - 01/2017
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 01/2017
6EnzymesIBA
10/2022 - 01/2017
6ChromatinIBA
01/2022 - 01/2012
6Histones (Histone)IBA
01/2022 - 01/2012
6ZincIBA
09/2021 - 01/2019
6AGRO 100IBA
04/2020 - 01/2018
5Methotrexate (Mexate)FDA LinkGeneric
04/2022 - 01/2020
5Sirtuin 1IBA
12/2021 - 07/2013
5Phosphotransferases (Kinase)IBA
01/2021 - 01/2012
5Oxygen (Dioxygen)IBA
01/2021 - 11/2017
5ResveratrolIBA
04/2020 - 07/2013
5LigandsIBA
01/2020 - 06/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 01/2014
5CaspasesIBA
12/2018 - 03/2013
5nitrofenIBA
03/2016 - 02/2007
5tetrandrineIBA
03/2016 - 02/2007
4Interleukin-4 (Interleukin 4)IBA
07/2022 - 02/2020
4Immunoglobulin E (IgE)IBA
07/2022 - 01/2019
4OvalbuminIBA
02/2022 - 12/2021
4Hyaluronic Acid (Hyaluronan)IBA
01/2022 - 08/2018
4VaccinesIBA
12/2021 - 01/2021
4GenisteinIBA
05/2021 - 01/2019
4NucleotidesIBA
12/2020 - 06/2009
4CollagenIBA
03/2020 - 01/2015
4isovitexinIBA
01/2020 - 01/2019
3AntioxidantsIBA
01/2022 - 03/2020
3Interleukin-13IBA
12/2021 - 02/2020
3CateninsIBA
11/2021 - 04/2020
3LipidsIBA
02/2021 - 04/2003
3Protein Isoforms (Isoforms)IBA
01/2021 - 10/2014
3AlbuminsIBA
01/2021 - 11/2018
3trioctyl phosphine oxide (TOPO)IBA
01/2021 - 11/2015
3Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2011
3Small Nucleolar RNA (snoRNA)IBA
01/2021 - 01/2020
3InflammasomesIBA
01/2021 - 07/2013
3NucleolinIBA
11/2020 - 07/2019
3Cisplatin (Platino)FDA LinkGeneric
10/2020 - 08/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 12/2015

Therapy/Procedure

45Therapeutics
08/2022 - 11/2007
18Radiotherapy
01/2022 - 04/2011
11Drug Therapy (Chemotherapy)
01/2022 - 12/2013
6Photothermal Therapy
02/2022 - 01/2018
4Intravenous Injections
02/2022 - 10/2018
4Hepatectomy
01/2022 - 01/2017
4Blood Transfusion (Blood Transfusions)
10/2019 - 07/2015
3Photochemotherapy (Photodynamic Therapy)
08/2022 - 10/2019